Swedish Research Council Grants SEK 42M to OnkPat Team

The Swedish Research Council (Vetenskapsrådet) has awarded a total of approximately SEK 42 million in research funding to seven researchers at the Department of Oncology-Pathology. The grants span a period of three to six years.

Project grants

Marianne Farnebo has been awarded a project grant of SEK 5,400,000 over four years for the project "Investigating how RNA participates in DNA repair and its potential as cancer therapy" (cell and molecular biology).

Felix Haglund de Flon has been awarded a project grant of SEK 3,000,000 over three years for the project "The secrets of the sarcoma genome" (cancer and oncology; clinical laboratory medicine).

Thomas Helleday has been awarded a project grant of SEK 5,400,000 over four years for the project "Precision medicine treatment using uracil-induced replication stress" (basic cancer research; social pharmacy and clinical pharmacy; cell and molecular biology).

Ola Larsson has been awarded a project grant of SEK 5,400,000 over four years for the project "Evaluation of translation elongation as a target in cancer" (medical biosciences; basic cancer research).

Brinton Seashore-Ludlow has been awarded a project grant of SEK 5,400,000 over four years for the project "Decoding and therapeutic exploitation of the dynamic plasticity landscape in ovarian cancer" (biomedical laboratory science/technology; cancer and oncology; basic cancer research).

Grant for research time

Alexios Matikas has been awarded a research time grant of SEK 11,100,000 over six years for the project "Integrated multi-omics analysis for predicting treatment response to antibody-drug conjugates" (cancer and oncology).

Establishment grant

Krzysztof Szkop has been awarded an establishment grant of SEK 6,000,000 over four years for the project "Spatial regulation of isoform-level translation: a key factor in ASD brain pathology" (medical bioinformatics and systems biology; bioinformatics and computational biology; neurosciences).

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.